Dimethylarginine Dimethylaminohydrolase Overexpression Ameliorates Atherosclerosis in Apolipoprotein E-Deficient Mice by Lowering Asymmetric Dimethylarginine

Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, is increasingly recognized as a novel biomarker in cardiovascular disease. To date, it remains unclear whether elevated ADMA levels are merely associated with cardiovascular risk or whether this molecule is of func...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Jacobi, Johannes, Maas, Renke, Cardounel, Arturo J., Arend, Michaela, Pope, Arthur J., Cordasic, Nada, Heusinger-Ribeiro, Juliane, Atzler, Dorothee, Strobel, Joachim, Schwedhelm, Edzard, Böger, Rainer H., Hilgers, Karl F.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Investigative Pathology 2010
נושאים:
Regular Articles
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2861120/
https://ncbi.nlm.nih.gov/pubmed/20348244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2353/ajpath.2010.090614
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים